SASCRO Statement on IORT

The aim of lumpectomy and post-operative irradiation for selected patient with early breast cancer is preservation of the breast while

SASCRO Endorsement of Meetings

SASCRO offers endorsements of academic meetings and allows the use of the SASCRO logo provided that the SASCRO has a

SASCRO Statement on Photodynamic Therapy

Photodynamic Therapy (PDT) refers to the administration to patients, of a drug (called a photosensitiser). The drug may be given

Trans Oral Robotic Surgery (TORS) and Chemo-Radiation

A series of two-page advertisements have appeared in the September and November 2016 issues of the SAMJ, entitled ‘da Vinci

SASCRO Guidelines for CPD Accreditation of Meetings

The primary purpose of CPD activities is to address the educational needs of medical doctors and other health care providers

SASCRO Prostate Brachytherapy Guidelines Task Group

These guidelines are a tool to assist medical practitioners in providing evidence based care for patients receiving prostate brachytherapy. They

SASCRO Statement on Unsealed Radio-Active Isotopes

Unsealed radio-active isotopes may be used to treat selected patients with cancer, for example, patients with cancer of the thyroid,

Quantitative Analysis of Normal Tissue Effects

The Quantitative Analysis of normal tissue effects in the clinic review summarized the currently available 3D dose/volume/outcome data to update

Stereotactic Ablative Body Radiotherapy

This document, endorsed by the Faculty of Clinical Oncology of The Royal College of Radiologists, intends to provide guidance on

Chemo Fee Rules

Code descriptions, interpretation and guidelines for use by medical oncologists (PR 23*), clinical and radiation oncologists (PR 40*), pediatric oncologists